Literature DB >> 6258177

Differentiation of opiate receptors in the brain by the selective development of tolerance.

R Schulz, M Wüster, A Herz.   

Abstract

The selective development to either the delta-opiate receptor agonist D-Ala2,D-Leu5-enkephalin (DADL) or the mu-agonist sufentanyl (SUF) has been studied in the central nervous system of rats by use of osmotic minipumps for chronic administration of the drugs. The opiate-sensitive parameters analgesia and catatonia were investigated. Chronic intracerebroventricular infusion of DADL for 7 days produced a 15-fold shift in that for catatonia. In these rats, the potency of SUF in inducing analgesia and catatonia did not differ between DADL-treated animals and saline-infused controls. Similarly, chronic infusion of SUF resulted in tolerance towards SUF for both analgesia and catatonia. In these animals, DADL displayed a similar degree of tolerance w.r.t. its ability to evoke analgesia, whilst no tolerance could be detected for DADL-induced catatonia. The data indicate that prolonged stimulation of specific opiate receptors in the brain by selective agonists may bring about the selective development of tolerance for particular receptors. The data conflict with the notion that mu-receptors specifically mediate analgesia and delta-receptors catatonia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6258177     DOI: 10.1016/0091-3057(81)90105-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Chronic opioids impair acquisition of both radial maze and Y-maze choice escape.

Authors:  J W Spain; G C Newsom
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Opioid receptor subtype-specific cross-tolerance to the effects of morphine on schedule-controlled behavior in mice.

Authors:  R E Solomon; J E Goodrich; J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Selective changes in mu opioid receptor properties induced by chronic morphine exposure.

Authors:  L L Werling; P N McMahon; B M Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.

Authors:  M J Picker; S S Negus; K R Powell
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions.

Authors:  J E Dum; A Herz
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

6.  Similarities and differences between D-ALA2 MET5 enkephalin amide and morphine in the induction of tolerance to their effects on catalepsy and on dopamine metabolism in the rat brain.

Authors:  M G De Simoni; V Guardabasso; K Misterek; S Algeri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.